Reaction of Geldanamycin and C17-Substituted Analogues with Glutathione: Product Identifications and Pharmacological Implications-Reference-Cited by-同舟云学术

Reaction of Geldanamycin and C17-Substituted Analogues with Glutathione: Product Identifications and Pharmacological Implications

Published:2006-02-07 Issue:3 Volume:19 Page:376-381
ISSN:0893-228X
Container-title:Chemical Research in Toxicology
language:en
Short-container-title:Chem. Res. Toxicol.

Author:

Cysyk Richard L.¹,Parker Robert J.¹,Barchi Joseph J.¹,Steeg Patricia S.¹,Hartman Neil R.¹,Strong John M.¹

Affiliation:

1. Laboratory of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20993, Molecular Therapeutics Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, and Laboratory of Medicinal Chemistry, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702

Publisher

American Chemical Society (ACS)

Subject

Toxicology,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/tx050237e

Reference29 articles.

1. Dose-intensive therapy in lung cancer

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Drugs with High Efficacy against Tumor Angiogenesis;International Journal of Molecular Sciences;2022-06-22

2. Structural diversity and biological relevance of benzenoid and atypical ansamycins and their congeners;Natural Product Reports;2022

3. Anticancer activity and toxicity of new quaternary ammonium geldanamycin derivative salts and their mixtures with potentiators;Journal of Enzyme Inhibition and Medicinal Chemistry;2021-01-01

4. Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges;European Journal of Medicinal Chemistry;2020-09

5. AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo;Biochemical Pharmacology;2020-02